Taladren en es it fr

Taladren Brand names, Taladren Analogs

Taladren Brand Names Mixture

  • No information avaliable

Taladren Chemical_Formula


Taladren RX_link


Taladren fda sheet

Taladren FDA

Taladren msds (material safety sheet)

Taladren MSDS

Taladren Synthesis Reference

No information avaliable

Taladren Molecular Weight

303.137 g/mol

Taladren Melting Point

122.5 oC

Taladren H2O Solubility

No information avaliable

Taladren State


Taladren LogP


Taladren Dosage Forms

Tablet (25, 50 mg); Powder for solution

Taladren Indication

For the treatment of high blood pressure and edema caused by diseases like congestive heart failure, liver failure, and kidney failure.

Taladren Pharmacology

Ethacrynic acid is a monosulfonamyl loop or high ceiling diuretic. Ethacrynic acid acts on the ascending limb of the loop of Henle and on the proximal and distal tubules. Urinary output is usually dose dependent and related to the magnitude of fluid accumulation. Water and electrolyte excretion may be increased several times over that observed with thiazide diuretics, since ethacrynic acid inhibits reabsorption of a much greater proportion of filtered sodium than most other diuretic agents. Therefore, ethacrynic acid is effective in many patients who have significant degrees of renal insufficiency. Ethacrynic acid has little or no effect on glomerular filtration or on renal blood flow, except following pronounced reductions in plasma volume when associated with rapid diuresis.

Taladren Absorption

Onset of action is rapid, usually within 30 minutes after an oral dose of ethacrynic acid or within 5 minutes after an intravenous injection of ethacrynic acid.

Taladren side effects and Toxicity

Overdosage may lead to excessive diuresis with electrolyte depletion.

Taladren Patient Information

No information avaliable

Taladren Organisms Affected

Humans and other mammals